期刊文献+

皮质抑素在慢性阻塞性肺疾病大鼠中的变化及其意义 被引量:6

Role of cortistain alternation in rats with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的 探讨皮质抑素在慢性阻塞性肺疾病(慢阻肺)大鼠中的变化及其意义.方法 16只健康雄性SD大鼠按随机数字表法随机分为对照组、慢阻肺组各8只;慢阻肺组给予被动烟雾吸入,对照组呼吸清洁空气.4个月后测定大鼠肺功能,支气管肺泡灌洗进行细胞学分类计数,取肺组织切片进行HE染色,观察肺组织病理形态改变.采用放免法检测大鼠血浆、支气管肺泡灌洗液(BALF)及肺组织中皮质抑素的表达水平.结果 慢阻肺组气道阻力、BALF嗜中性粒细胞百分比均显著高于对照组[(0.584±0.021)比(0.653 ±0.062) mmHg·ml-1·s-1、1.49%比0.41%](均P<0.05);慢阻肺组呈现明显的气道炎症和肺气肿改变;慢阻肺组血浆、BALF、肺组织中皮质抑素均显著高于对照组[(526 ±76)比(453±41) pg/ml、(819±100)比(619±101) pg/ml、(41±10)比(20±7)pg/mg](均P <0.05).结论 皮质抑素在慢阻肺大鼠中表达增加,参与其气道炎症反应,可能具有抗炎保护作用. Objective To explore the role of cortistatin (CST) in rats with chronic obstructive pulmonary disease (COPD).Methods A total of 16 healthy male Sprague-Dawley rats were randomly divided into control and COPD model groups (n =8 each).The COPD model group received an inhalation of passive smoking while the control group was treated normally.After 4 months,pulmonary function was measured.The differential cell counts of bronchoalveolar lavage fluid (BALF) were detected.Morphology and pathology of lungs were studied via hematoxylin and eosin staining.The levels of CST in lung tissue,serum and BALF were detected by radioimmunoassay.Results Compared with the control group,the COPD group had obviously higher airway resistance and neutrophil ratio in BALF [(0.584 ±0.021) vs (0.653 ± 0.062) mmHg · ml-1 · s-1,1.49% vs 0.41%,both P 〈 0.05].And there were significantly serious inflammation and emphysema in lung tissues.Moreover,the levels of CST increased in serum,BALF and lung tissues [(526 ±76) vs (453 ±41)pg/ml,(819 ± 100) vs (619 ± l01)pg/ml,(41 ± 10) vs (20 ±7)pg/mg,all P 〈 0.05] respectively as compared with the controls.Conclusion An elevated level of CST may compensate to exert anti-inflammation effects in COPD rats.
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第22期1722-1725,共4页 National Medical Journal of China
基金 国家自然科学基金(81170012,81370141)
关键词 肺疾病 慢性阻塞性 皮质抑素 大鼠 Pulmonary disease,chronic obstructive Cortistatin Rats
  • 相关文献

参考文献15

  • 1Angelis N,Porpodis K,Zarogoulidis P,et al.Airway inflammation in chronic obstructive pulmonary disease[J].J Thorac Dis,2014,6 Suppl 1:S167-S172.
  • 2贺蓓.对慢性阻塞性肺疾病气道炎症的认识有待于进一步深人[J].中华医学杂志,2008,88(30):2089-2091. 被引量:2
  • 3Chen YH,Wang PP,Wang XM,et al.Involvement of endogenous hydrogen sulfide in cigarette smoke-induced changes in airway responsiveness and inflammation of rat lung[J].Cytokine,2011,53 (3):334-341.
  • 4Chen YH,Wu R,Geng B,et al.Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma[J].Cytokine,2009,45(2):117-123.
  • 5Cosio M,Ghezzo H,Hogg JC,et al.The relations between structural changes in small airways and pulmonary-function tests[J].N Engl J Med,1978,298(23):1277-1281.
  • 6柴三葆,惠永明,庞永正,唐朝枢.冠心病患者经皮冠状动脉介入治疗术后血浆皮质抑素的变化及临床意义[J].中国循环杂志,2010,25(1):22-25. 被引量:7
  • 7Fukusumi S,Kitada C,Takekawa S,et al.Identification and characterization of a novel human cortistatin-like peptide[J].Biochem Biophys Res Commun,1997,232 (1):157-163.
  • 8Deghenghi R,Papotti M,Ghigo E,et al.Cortistatin,but not somatostatin,binds to growth hormone secretagogue (GHS) receptors of human pituitary gland[J].J Endocrinol Invest,2001,24 (1):RC1-RC3.
  • 9Robas N,Mead E,Fidock M.MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion[J].J Biol Chem,2003,278 (45):44400-44404.
  • 10Dalm VA,Van Hagen PM,de Krijger RR,et al.Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues[J].Clin Endocrinol (Oxf),2004,60 (5):625-629.

二级参考文献34

  • 1Gamble E, Grootendorst DC, Hattotuwa K, et al. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. Eur Respir J, 2007, 30: 467-471.
  • 2Rutgers SR, Postma DS, ten Hacken NH, et al. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax, 2000, 55: 12-18.
  • 3Curtis JL, Freeman CM, Hogg JC. The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc, 2007, 4:512-521.
  • 4Siddiqui S, Hollins F, Saha S, et al. Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur Respir J, 2007, 30: 1043-1056.
  • 5Baraldo S, Turato G, Badin C, et al. Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax, 2004, 59:308-312.
  • 6Zhu J, Qiu Y, Valobra M, et al. Plasma cells and IL-4 in chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2007, 175:1125-1133.
  • 7Groenewegen KH, Postma DS, Hop WC, et al. Increased systemic inflammation is a risk factor for COPD exacerbations. Chest, 2008, 133:350-357.
  • 8Sin DD, Lacy P, York E, et al. Effects of futicasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004, 170:760-765.
  • 9Huiart L, Ernst P, Ranouil X, et al. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J, 2005, 25:634-639.
  • 10Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 2007, 356:775-789.

共引文献7

同被引文献47

引证文献6

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部